| # | Title | Journal | Year | Citations |
|---|
| 1 | Cholangiocarcinoma 2020: the next horizon in mechanisms and management | Nature Reviews Gastroenterology and Hepatology | 2020 | 1,155 |
| 2 | Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis | Cell | 2018 | 350 |
| 3 | Microbial network disturbances in relapsing refractory Crohn’s disease | Nature Medicine | 2019 | 277 |
| 4 | Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation | Nature Communications | 2017 | 224 |
| 5 | Growth of Epithelial Organoids in a Defined Hydrogel | Advanced Materials | 2018 | 200 |
| 6 | Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II) | Gut | 2019 | 132 |
| 7 | Succinate receptor mediates intestinal inflammation and fibrosis | Mucosal Immunology | 2019 | 122 |
| 8 | Liver Allograft Failure After Nivolumab Treatment—A Case Report With Systematic Literature Research | Transplantation Direct | 2018 | 98 |
| 9 | Intestinal microbiota and colorectal carcinoma: Implications for pathogenesis, diagnosis, and therapy | EBioMedicine | 2019 | 72 |
| 10 | Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors | Cell Host and Microbe | 2021 | 71 |
| 11 | Association of Alterations in Intestinal Microbiota With Impaired Psychological Function in Patients With Inflammatory Bowel Diseases in Remission | Clinical Gastroenterology and Hepatology | 2020 | 64 |
| 12 | PTPN2 Regulates Interactions Between Macrophages and Intestinal Epithelial Cells to Promote Intestinal Barrier Function | Gastroenterology | 2020 | 62 |
| 13 | Challenges in the Pathophysiology, Diagnosis, and Management of Intestinal Fibrosis in Inflammatory Bowel Disease | Gastroenterology | 2022 | 48 |
| 14 | Active Helicobacter pylori Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients | Journal of Clinical Medicine | 2020 | 48 |
| 15 | Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and microbiological factors associated with patient outcomes | American Journal of Clinical Nutrition | 2021 | 45 |
| 16 | β6‐integrin serves as a novel serum tumor marker for colorectal carcinoma | International Journal of Cancer | 2019 | 42 |
| 17 | The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitis | Mucosal Immunology | 2019 | 40 |
| 18 | Lack of the pH-sensing Receptor TDAG8 [GPR65] in Macrophages Plays a Detrimental Role in Murine Models of Inflammatory Bowel Disease | Journal of Crohn's and Colitis | 2019 | 39 |
| 19 | Alzheimer’s disease and gastrointestinal microbiota; impact of Helicobacter pylori infection involvement | International Journal of Neuroscience | 2021 | 38 |
| 20 | Dysbiotic microbiota interactions in Crohn’s disease | Gut Microbes | 2021 | 38 |
| 21 | Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis | Journal of Lipid Research | 2019 | 37 |
| 22 | ECCO Guidelines on Inflammatory Bowel Disease and Malignancies | Journal of Crohn's and Colitis | 2023 | 36 |
| 23 | The presence of genetic risk variants within PTPN2 and PTPN22 is associated with intestinal microbiota alterations in Swiss IBD cohort patients | PLoS ONE | 2018 | 35 |
| 24 | Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn’s Disease | Gastroenterology | 2018 | 34 |
| 25 | The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort | Inflammatory Bowel Diseases | 2018 | 32 |
| 26 | Spermidine and spermine exert protective effects within the lung | Pharmacology Research and Perspectives | 2021 | 31 |
| 27 | Vaccination in Patients with Inflammatory Bowel Diseases | Digestion | 2020 | 29 |
| 28 | Succinate Activates EMT in Intestinal Epithelial Cells through SUCNR1: A Novel Protagonist in Fistula Development | Cells | 2020 | 27 |
| 29 | Management of the Elderly Inflammatory Bowel Disease Patient | Digestion | 2020 | 27 |
| 30 | New insights into the pathophysiology of inflammatory bowel disease: microbiota, epigenetics and common signalling pathways | Swiss Medical Weekly | 2018 | 27 |
| 31 | Genetics and epigenetics of inflammatory bowel disease | Swiss Medical Weekly | 2018 | 27 |
| 32 | Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study | PLoS ONE | 2019 | 26 |
| 33 | Factors Promoting Development of Fibrosis in Crohn’s Disease | Frontiers in Medicine | 2017 | 24 |
| 34 | The impact of the rs8005161 polymorphism on G protein-coupled receptor GPR65 (TDAG8) pH-associated activation in intestinal inflammation | BMC Gastroenterology | 2019 | 24 |
| 35 | Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis | Scientific Reports | 2018 | 20 |
| 36 | Uveitis manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study | Therapeutic Advances in Gastroenterology | 2019 | 20 |
| 37 | The oxysterol receptor GPR183 in inflammatory bowel diseases | British Journal of Pharmacology | 2021 | 20 |
| 38 | Nutritional Lipids and Mucosal Inflammation | Molecular Nutrition and Food Research | 2021 | 20 |
| 39 | Depressive Symptoms Predict Clinical Recurrence of Inflammatory Bowel Disease | Inflammatory Bowel Diseases | 2022 | 20 |
| 40 | Rodent models of obesity | Minerva Endocrinologica | 2020 | 20 |
| 41 | Ingested nano- and microsized polystyrene particles surpass the intestinal barrier and accumulate in the body | NanoImpact | 2022 | 20 |
| 42 | Allogeneic expanded adipose‐derived mesenchymal stem cell therapy for perianal fistulas in Crohn’s disease: A case series | Colorectal Disease | 2021 | 19 |
| 43 | Clinicopathological and Molecular Specificities of Inflammatory Bowel Disease–Related Colorectal Neoplastic Lesions: The Role of Inflammation | Journal of Crohn's and Colitis | 2018 | 18 |
| 44 | Tofacitinib, an Oral Janus Kinase Inhibitor: Analysis of Malignancy (Excluding Nonmelanoma Skin Cancer) Events Across the Ulcerative Colitis Clinical Program | Inflammatory Bowel Diseases | 2021 | 18 |
| 45 | Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases | The Lancet Gastroenterology and Hepatology | 2022 | 18 |
| 46 | The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort | PLoS ONE | 2019 | 15 |
| 47 | Clinical Relevance of Anti-TNF Antibody Trough Levels and Anti-Drug Antibodies in Treating Inflammatory Bowel Disease Patients | Inflammatory Intestinal Diseases | 2021 | 15 |
| 48 | Protein tyrosine phosphatase non-receptor type 22 modulates colitis in a microbiota-dependent manner | Journal of Clinical Investigation | 2019 | 15 |
| 49 | Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer | | 2022 | 15 |
| 50 | Protein Tyrosine Phosphatase Non-Receptor Type 2 Function in Dendritic Cells Is Crucial to Maintain Tissue Tolerance | Frontiers in Immunology | 2020 | 14 |
